We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

DaVita To Pay Record $495M To Settle Kidney Drug FCA Suit

Law360, Los Angeles (May 4, 2015, 10:01 PM EDT) -- DaVita Inc. said Monday it set aside $495 million as part of a tentative deal to resolve a False Claims Act whistleblower suit for allegedly bilking taxpayers for reimbursement of intentionally...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.